The Sympathetic Nervous System
Desensitization and Tachyphylaxis
Adrenergic Agonists: Therapeutic Uses
Sympathetic Signaling
Sympathetic Activation
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 13, 2026

Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
W Kupper1, H H Erlemeier, W Bleifeld
1Department of Cardiology, University Hospital Eppendorf, Hamburg, F.R.G.
Xamoterol, a beta 1-selective adrenoceptor partial agonist, improved exercise capacity in patients with mild to moderate heart failure. This study highlights its potential as a promising treatment option.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: